Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01574079 · ClinicalTrials.gov registry record · NA
Effect of Mirror Therapy on Lower Extremity Motor Control and Gait in Patients With Stroke
A NA study, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01574079: Completed NA study, sponsored by University of Mississippi Medical Center.
NCT01574079 is a NA study that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01574079, a NA study, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Mirror therapy may be an effective intervention in increasing motor control and gait performance in patients with stroke.
Primary Outcome
The Functional Independence Measure (FIM)assesses level of disability and measures progress toward independence with rehabilitational intervention. The tool consists of 18 items. Only the the locomotor score was used to assess gait ability in this study. The locomotor score ranges from 1 - 7 with a higher score indicating a higher level of functional independence.
Interventions
- OTHER Traditional Physical Therapy
- OTHER Physical Therapy plus Mirror Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-11 |
| Phase | NA |
What the finished NCT01574079 record still lists
NCT01574079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Traditional Physical Therapy is the first listed.
NCT01574079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01574079 about?
NCT01574079 is a clinical study titled "Effect of Mirror Therapy on Lower Extremity Motor Control and Gait in Patients With Stroke". Mirror therapy may be an effective intervention in increasing motor control and gait performance in patients with stroke.
What is the current status of trial NCT01574079?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2010-11. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01574079?
The interventions under investigation include: Traditional Physical Therapy (OTHER), Physical Therapy plus Mirror Therapy (OTHER).
Who is sponsoring clinical trial NCT01574079?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01574079's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia